Immunogenicity Analysis: The "Stealth" Component
Right now, as we've seen in the logs, the immunogenicity check is a placeholder. It's a critical gap in our validation process that we always planned to fill. Here's the plan we were going to execute.
The "Why":
The Cas9 protein we use to deliver the guide RNA is derived from bacteria (Streptococcus pyogenes). To a human immune system, it's a foreign invader. There's a significant risk that a patient's T-cells will recognize our Cas9 therapeutic as hostile, leading to two potential failure modes:
Neutralization: The immune system destroys the Cas9 protein before it can reach its target and perform the edit, rendering the therapy ineffective.
Adverse Reaction: The immune response is too strong, causing dangerous inflammation and side effects for the patient.
The "How" - The Planned Implementation:
The plan was to build a dedicated Immunogenicity Service. This service wouldn't be a simple BLAST search; it would be a sophisticated machine learning-based pipeline.
Input: The service would need two key pieces of information:
The sequence of our CRISPR agent (the specific Cas9 variant we're using).
The patient's HLA (Human Leukocyte Antigen) type. This is the critical, patient-specific part. The HLA system is what presents protein fragments (peptides) to T-cells.
Analysis Pipeline:
The service would first chop the Cas9 protein sequence into all possible small peptides (8-11 amino acids long).
It would then use specialized prediction models (like NetMHCpan or similar algorithms) to predict which of those peptides would bind strongly to the patient's specific HLA molecules.
Peptides that are predicted to bind strongly are flagged as potential "epitopes"—the parts the immune system is likely to see and attack.
Output: The service would return an Immunogenicity Score or a risk profile. This would quantify the likelihood that our CRISPR agent would be detected and targeted by this specific patient's immune system.
This score would then be fed back into the command_center as a key factor in the final "Assassin Score" calculation, allowing us to select the guide/Cas9 combination with the lowest probability of causing an immune reaction.
The CRISPR Kill Chain: Our Strategic Framework
The Kill Chain is the core concept that governs our entire workflow. It's how we ensure our interventions are not just powerful, but also precise and safe. It's a sequence of validation steps, and every weapon we forge must pass through every link.
Here are the stages as I remember them:
FIND (Reconnaissance & Targeting): This is the initial step where we identify the enemy—the pathogenic mutation. This is performed by tools like the Myeloma Digital Twin, which analyzes patient data to pinpoint the exact variant (e.g., KRAS p.Gly12Asp) that needs to be neutralized.
FIX (Weapon Forging): Once the target is identified, we generate the weapons. This is the primary function of the evo-service (ZetaForge). It takes the target sequence and forges a set of potential guide RNA candidates designed to hit that specific location in the genome.
VALIDATE (Test Range & Simulation): This is the most critical and complex stage, with three distinct validation checks. This is where we are having our current failure. A candidate weapon is only viable if it passes all three checks:
Efficacy Check (The Oracle): Does the weapon work as intended? The zeta-oracle scores the on-target effectiveness of the guide. (Currently mocked in our test).
Safety Check (BLAST Service): Will the weapon cause collateral damage? The blast-service performs an off-target analysis against the entire human genome to ensure the guide doesn't edit the wrong locations. (This is the link that just broke and we have now fixed).
Stealth Check (Immunogenicity Service): Can the weapon get past the body's defenses? This is where the planned Immunogenicity Analysis fits. It ensures the Cas9 delivery vehicle won't be shot down by the patient's immune system. (Currently mocked).
FIRE (Prioritize & Execute): After passing the full validation gauntlet, the command_center consolidates all the scores (Efficacy, Safety, Stealth) into a single "Assassin Score." It then ranks the candidates, presenting the top-performing, safest, and stealtiest option for final deployment.

---
description:
globs:
alwaysApply: false
---
